The National Cancer Data Base report on prostate carcinoma after the peak in incidence rates in the U.S. The American College of Surgeons Commission on Cancer and the American Cancer Society.
about
Prevalence of pesticide exposure in young males (</= 50 years) with adenocarcinoma of the prostateEndocrine treatment in prostate cancerSurgical and postoperative factors affecting length of hospital stay after radical prostatectomy.Second malignancies in prostate carcinoma patients after radiotherapy compared with surgery.PSA screening: the bottom line.Impact of screening on prostate cancer rates and trends.Staging prostate cancer.Novel diagnostic biomarkers for prostate cancer.Salvage cryotherapy for radiation-recurrent prostate cancer: outcomes and complications.The National Prostate Cancer Register in Sweden 1998-2002: trends in incidence, treatment and survival.MR-guided interventions of the prostate gland.Differential dose contributions on total dose distribution of (125)I brachytherapy source.Molecular biomarkers in prostate cancer.Evaluation of prostate cancer patients receiving multiple staging tests, including ProstaScint scintiscans.Effect of cyclin G2 on proliferative ability of prostate cancer PC-3 cell.Venous thromboembolism after radical prostatectomy: the effect of surgical caseload.Effect of androgen deprivation therapy on quality of life in Japanese men with prostate cancer.Patient outcomes and length of hospital stay after radical prostatectomy for prostate cancer: analysis of hospital episodes statistics for England.Value of contrast ultrasonography in the detection of significant prostate cancer: correlation with radical prostatectomy specimens.
P2860
Q24792282-26A348BA-149E-41E7-8DE3-6014C2EE5655Q28378298-A5BA2F45-69F2-4D26-A042-C91CA2B32544Q30305900-CAED631B-4E93-48E2-89B1-643ABFA4E7B2Q33887078-7F0DFB2D-A4F5-4251-A0B3-91B4E057DD95Q34034684-37968C38-069C-44D8-95E5-C61EC744D6AFQ34080713-0A7EA040-E0EE-4374-B8AF-F35D9ED5A4A3Q34080722-12E3B500-1FA2-4BF1-B44F-97848B9669E0Q34231678-8EF7E2BE-E05E-4919-8F5B-5ABC53368766Q34627488-DE6D492A-B894-45E1-94D8-067939C9E190Q36194987-14846E91-D593-4DD3-A381-DC56BE9540C2Q36925614-5C4C7B83-606A-41D3-A98A-896BFF56642DQ37392435-4E9243D9-4070-42CA-A718-23B3166702D6Q38088854-470247D3-D459-4322-AFEC-8CFDB77472C9Q38466338-FB8C3B42-91BD-43BE-8566-074E7B1EAB55Q39051459-E5ADAF2D-A634-43C7-986E-D228EAFCACEAQ42635347-3CB52841-8519-4D43-BD71-5CF9BB9697C1Q46005833-CAD98F34-DDF9-43C9-9DCB-44B281AF7BECQ50146346-194DE17E-564E-4CD9-AD6A-ACF144B9679AQ52944825-330ED5EF-FFA1-42FD-BFAD-867E91E05B42
P2860
The National Cancer Data Base report on prostate carcinoma after the peak in incidence rates in the U.S. The American College of Surgeons Commission on Cancer and the American Cancer Society.
description
1998 nî lūn-bûn
@nan
1998 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
The National Cancer Data Base ...... d the American Cancer Society.
@ast
The National Cancer Data Base ...... d the American Cancer Society.
@en
type
label
The National Cancer Data Base ...... d the American Cancer Society.
@ast
The National Cancer Data Base ...... d the American Cancer Society.
@en
prefLabel
The National Cancer Data Base ...... d the American Cancer Society.
@ast
The National Cancer Data Base ...... d the American Cancer Society.
@en
P2093
P2860
P1433
P1476
The National Cancer Data Base ...... d the American Cancer Society.
@en
P2093
Mettlin CJ
Rosenthal DS
P2860
P304
P356
10.1002/(SICI)1097-0142(19981015)83:8<1679::AID-CNCR24>3.0.CO;2-Y
P407
P577
1998-10-01T00:00:00Z